2025 Senate Bill 3

Health: pharmaceuticals; prescription drug cost and affordability review act; create.

A bill to provide for a cost and affordability review of certain prescription drug products; to create the prescription drug pricing board and prescription drug affordability stakeholder council and to prescribe their powers and duties; to provide for the powers and duties of certain state governmental officers and entities; to establish upper payment limits for certain prescription drug products and provide remedies; and to provide for the promulgation of rules.

AI Analysis – Experimental

This legislative package (SB 3-5) establishes a board and council to review prescription drug costs in Michigan, set upper payment limits if necessary, and is funded by a dedicated state fund.

Introduced in the Senate

Jan. 8, 2025

Introduced by Sen. Darrin Camilleri (D-4)

Referred to the Committee on Finance, Insurance, and Consumer Protection

April 23, 2025

Reported with substitute S-1

April 24, 2025

Referred to the Committee of the Whole

Reported with substitute S-1

Substitute S-1 concurred in by voice vote

Amendment offered by Sen. Jim Runestad (R-23)

1. Amend page 4, line 23, after “state” by inserting “or if the individual has made a personal political contribution to the governor”.

The amendment failed by voice vote

Amendment offered by Sen. Jonathan Lindsey (R-17)

1. Amend page 12, following line 17, by inserting:

“(k) The average monetary price concession, discount, or rebate that is retained by pharmacy benefit managers in this state compared to the average monetary price concession, discount, or rebate that is passed on to prescription drug product purchasers.

(l) The average monetary concession, discount, or rebate that prescription drug product purchasers retain compared to the average monetary concession, discount, or rebate that is passed on to patients.” and relettering the remaining subdivision.

The amendment failed by voice vote

Amendment offered by Sen. Aric Nesbitt (R-20)

1. Amend page 16, following line 7, by inserting:

“Sec. 27. This act does not apply beginning 3 years after the effective date of this act.”.

The amendment failed by voice vote

Amendment offered by Sen. Michael Webber (R-9)

1. Amend page 4, line 15, after “administration.” by inserting “At least 1 member of the board must be an individual who advocates for patients.”.

The amendment passed by voice vote

Passed in the Senate 20 to 15 (details)

Received in the House

April 24, 2025

Referred to the Committee on Government Operations